{
    "Trade/Device Name(s)": [
        "accessa Cholesterol Panel"
    ],
    "Submitter Information": "Home Access Health Corporation",
    "510(k) Number": "K063852",
    "Predicate Device Reference 510(k) Number(s)": [
        "K012221",
        "K891922",
        "K801834",
        "K801298"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JKA",
        "LBS",
        "JGY",
        "CHH"
    ],
    "Summary Letter Date": "October 30, 2007",
    "Summary Letter Received Date": "October 31, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1175",
        "21CFR862.1475",
        "21CFR862.1705",
        "21CFR864.3250"
    ],
    "Regulation Name(s)": [
        "Blood specimen collection device",
        "Cholesterol test system",
        "HDL cholesterol test system",
        "Triglyceride test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total Cholesterol",
        "HDL-Cholesterol",
        "Triglycerides",
        "Calculated LDL-Cholesterol"
    ],
    "Specimen Type(s)": [
        "Dried micro-serum"
    ],
    "Specimen Container(s)": [
        "Blood collection/transportation cassette"
    ],
    "Instrument(s)/Platform(s)": [
        "Roche Cobas Mira Plus chemical analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "In vitro quantitative determination using FDA-cleared reagent assays"
    ],
    "Methodologies": [
        "Clinical chemistry assay"
    ],
    "Submission Type(s)": [
        "Panel",
        "Specimen collection device",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for accessa Cholesterol Panel kit and capillary blood self-collection system for laboratory lipid profile testing",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of Total Cholesterol, HDL-Cholesterol, Triglycerides, and calculated LDL-Cholesterol in dried micro-serum samples; for diagnosis and treatment of lipid and lipoprotein metabolism disorders, excluding neonates and samples with triglycerides >400 mg/dL",
    "fda_folder": "Clinical Chemistry"
}